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domized clinical study to evaluate this hypothesis is justi-
fiable.
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Combined mitral valve repair and the Cox maze
procedure for mitral valve prolapse and regurgi-
tation and associated atrial fibrillation
To the Editor:
I read with great interest the report by Handa and associ-
ates1 on the early and intermediate term results of combined
mitral valve repair and the Cox maze procedure for patients
with severe mitral regurgitation and associated atrial fibrilla-
tion. It is gratifying to note that at the Mayo Clinic the addi-
tion of the Cox maze procedure to mitral valve repair not only
is safe and effective but also decreases late complications.
One of the serious complications of mitral valve prolapse,
which is otherwise a common2 and benign3 condition, is
mitral regurgitation.4,5 In fact, the commonest cause of mitral
regurgitation in the United States is mitral valve prolapse.5,6
Mitral regurgitation in mitral valve prolapse may become
progressive in some patients.5 One of the serious complica-
tions of progressive mitral regurgitation is atrial fibrillation,
which usually persists even after successful corrective
surgery of the mitral valve and often recurs after pharmaco-
logic or electric cardioversion. Although postoperative atrial
fibrillation can be successfully managed by antiarrhythmic
drugs and long-term anticoagulant therapy to prevent throm-
boembolism, these therapeutic modalities are not without
side-effects, torsades de pointes and bleeding, respectively. It
is gratifying that the adjunctive Cox maze procedure at the
Mayo Clinic increased the restoration of sinus rhythm to 82%
of their patients.
Therefore, as the authors concluded, “Although the addi-
tion of the Cox maze procedure lengthens hospital stay in
patients having mitral valve repair, overall medical costs may
be decreased by reducing the need for long-term anticoagula-
tion, as well as costs associated with stroke and bleeding
complications.”1
Tsung O. Cheng, MD
Professor of Medicine
The George Washington University
Washington, DC 20037
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Should the bidirectional Glenn procedure be better
performed through the support of cardiopulmonary
bypass?
To the Editor:
We read with great interest the report of Jahangiri and asso-
ciates1 and the commentary by Jonas on the technique of bidi-
rectional Glenn shunt through a thoracotomy without the use
of cardiopulmonary bypass (CPB). We agree that clamping
the superior vena cava (SVC) without decompressing the
internal jugular system exposes the brain to the effects of
reduced cerebral perfusion pressure. We have used electro-
physiological indices of cerebral function (electroen-
cephalography or evoked potentials) and transcranial Doppler
during bidirectional Glenn shunts in patients with pulmonary
atresia without support (n = 2) or through the use of CPB (n
= 4). During clamping of the SVC without CPB, major reduc-
tions (>50%) in the diastolic, mean, and peak systolic blood
flow velocities of the middle cerebral artery were identified,
which were followed by mild electrocortical alterations as
indicated by longer latencies of the cortically generated
evoked potentials.2 In contrast, this situation did not occur or
was minimal in those cases in which clamping of the SVC
was done with the support of CPB. We have learned that
Doppler flow changes and electrocortical alterations may be
expected as a result of acute SVC hypertension if the internal
jugular venous system is not decompressed.3 In one of our
cases without CPB, an intraoperative shunt into the SVC was
indicated due to the presence of extremely low flow veloci-
ties and electrocortical alterations during SVC clamping. In
this case, while the SVC shunt was patent, flow velocities
were maintained and the latencies of evoked potentials
returned to preclamping levels.4 In our institution, we rou-
tinely use CPB and intraoperative brain function monitoring
by transcranial Doppler, near-infrared spectrophotometry,
and electroencephalography for children undergoing these
procedures.3 A note of caution should be made that the
reported absence of gross neurologic deficits in Jahangiri and
colleagues’ cases is not an indicator that the brain is free of
potential alterations during SVC clamping without CPB.
Furthermore, under conditions of normothermic ischemia,
the brain does not receive the protective benefit of hypother-
mia.5 Without brain protection, even short intervals of low
cerebral perfusion could generate minor or subclinical
deficits that might be detectable only through detailed cogni-
tive testing. We agree with Jonas’ comments that the demon-
stration of safety of this procedure will rest on the careful
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documentation of the neurodevelopmental and cognitive out-
come of these patients.
Rosendo A. Rodriguez, MD, PhD,
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Reply to the Editor:
We appreciate the comments of Rodriguez and colleagues.
Although the patient was not actively cooled, a low ambient
temperature allowed the patient’s body temperature to initial-
ly drift to around 33°C, necessitating active rewarming at the
end of the operation. It is known that moderate to mild (26°C-
35°C) hypoperfusion can attenuate the so-called excitotoxic
cascade associated with cerebral hypoperfusion. Similarly,
there is a fairly steep exponential fall in the cerebral meta-
bolic rate for oxygen, with temperatures ranging from nor-
mothermia to 35°C. These facts, taken together with the short
superior vena cava clamp time, should minimize the risk of
neurologic damage.
We will endeavor to supplement future attempts at per-
forming the bidirectional Glenn procedure without bypass
with near-infrared spectroscopy of transcranial Doppler
assessment of cerebral blood flow. In addition, we agree with
the authors that demonstrating the safety of this operation
will need detailed assessment of the patients by neurologic
and psychometric testing.
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Preimplantation retrograde pneumoplegia in clinical
lung transplantation
To the Editor:
I read with interest the article by Venuta and associates1
concerning 14 consecutive patients who underwent lung
transplantation. The first patients, group I, had antegrade
pneumoplegia with Euro-Collins solution preceded by pul-
monary arterial flushing with alprostadil (prostaglandin E1).
In group II, additional retrograde flushing was given via the
pulmonary veins just before implantation. The authors con-
cluded that retrograde flushing is not detrimental and helps to
improve early graft function. The chest x-ray score was sig-
nificantly better in group II, intubation time was less, and the
ratio of arterial PO2 to inspired oxygen fraction was
improved, although the differences did not reach statistical
significance.
My colleagues and I2 were the first group to use retrograde
pneumoplegia in clinical transplantation. However, we did
not use antegrade pneumoplegia in those patients, nor did we
use alprostadil. The retrograde pneumoplegic solution was
given via the left atrium and the flush solution was vented
through an incision in the pulmonary artery. This was done
immediately after the aorta was crossclamped and cardiople-
gia established. The lung almost seemed to light up as the ret-
rograde infusion started. Retrograde pneumoplegia was asso-
ciated with excellent oxygenation, which remains the most
sensitive indicator of the adequacy of lung preservation, as
well as the lack of any reimplantation response postopera-
tively, a finding also shown by the current study. What
Venuta’s study really demonstrates is that retrograde pneu-
moplegia may confer additional benefits to lung preservation
compared with those of antegrade pneumoplegia alone.
Two criticisms can be leveled at this study. First, retrograde
pneumoplegia was given after harvesting of the donor lung,
not at the time of the harvesting. This point has already been
addressed, and the current practice of the group is to give the
retrograde perfusion solution immediately after the antegrade
perfusion is finished. The second criticism is that pneumo-
plegic solution was given individually into each pulmonary
vein. This method is at variance with our technique, in which
the pneumoplegic solution was given into the left atrium and
therefore had a uniform distribution through both lungs,
something that cannot be guaranteed if individual veins are
perfused separately.
I do congratulate Venuta and his colleagues for highlight-
ing the potential advantage of retrograde pulmonary perfu-
sion in clinical lung transplantation.
Mazin A. I. Sarsam, FRCS
Cardiac Surgery
The Royal Victoria Hospital
Grosvenor Rd
Belfast BT12 6BA, Northern Ireland
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